In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Force Factor has one goal in mind and that is to make individuals more powerful, stronger and faster. Two Harvard University rowers in 2009 founded Force Factor. Even though the company is still young ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results